Clinical Trial Update: Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating intravenous L-Citrulline for vaso-occlusive pain episodes in sickle cell disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Vaso-occlusive Pain Episode

Drugs mentioned

• L-citrulline (L-citrulline)

Snippet

Sponsor: Suvankar Majumdar | Conditions: Sickle Cell Disease, Vaso-occlusive Pain Episode | Phase 2 | Status: RECRUITING